220 related articles for article (PubMed ID: 36264161)
21. New developments in extracutaneous lymphomas.
Chott A; Raderer M
Semin Cutan Med Surg; 2000 Jun; 19(2):149-56. PubMed ID: 10892718
[TBL] [Abstract][Full Text] [Related]
22. Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas.
Reimann M; Schrezenmeier J; Richter-Pechanska P; Dolnik A; Hick TP; Schleich K; Cai X; Fan DNY; Lohneis P; Maßwig S; Denker S; Busse A; Knittel G; Flümann R; Childs D; Childs L; Gätjens-Sanchez AM; Bullinger L; Rosenwald A; Reinhardt HC; Schmitt CA
Blood; 2021 May; 137(20):2785-2799. PubMed ID: 33232972
[TBL] [Abstract][Full Text] [Related]
23. CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis.
Ohshima K; Kawasaki C; Muta H; Muta K; Deyev V; Haraoka S; Suzumiya J; Podack ER; Kikuchi M
Histopathology; 2001 Aug; 39(2):156-62. PubMed ID: 11493332
[TBL] [Abstract][Full Text] [Related]
24. Standardized uptake value for (18)F-fluorodeoxyglucose is correlated with a high International Prognostic Index and the presence of extranodal involvement in patients with diffuse large B-cell lymphoma.
Akkas BE; Vural GU
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):148-52. PubMed ID: 24094371
[TBL] [Abstract][Full Text] [Related]
25. A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma, Nasal-type and Diffuse Large B-cell Lymphoma.
Kawai H; Matsushita H; Kawakami S; Furuya D; Shiraiwa-Hara S; Ichiki A; Hara R; Aoyama Y; Ogiya D; Suzuki R; Machida S; Onizuka M; Shirasugi Y; Ogawa Y; Kawada H; Nakamura N; Ando K
J Clin Exp Hematop; 2019; 59(1):34-39. PubMed ID: 30918142
[TBL] [Abstract][Full Text] [Related]
26. Extranodal diffuse large B cell lymphoma of cutaneous follicle centre lymphoma type: a study of 24 patients with non-cutaneous primary limited stage extranodal diffuse large B cell lymphoma in support of a new concept.
Aigner F; Korol D; Schmitt AM; Kurrer MO
Histopathology; 2012 Apr; 60(5):774-84. PubMed ID: 22304695
[TBL] [Abstract][Full Text] [Related]
27. Extranodal lymphoma.
Ferry JA
Arch Pathol Lab Med; 2008 Apr; 132(4):565-78. PubMed ID: 18384208
[TBL] [Abstract][Full Text] [Related]
28. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA; Olszewski AJ
Curr Treat Options Oncol; 2018 Jun; 19(8):38. PubMed ID: 29931605
[TBL] [Abstract][Full Text] [Related]
29. FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma.
Wohlfart S; Sebinger D; Gruber P; Buch J; Polgar D; Krupitza G; Rosner M; Hengstschläger M; Raderer M; Chott A; Müllauer L
Am J Pathol; 2004 Mar; 164(3):1081-9. PubMed ID: 14982861
[TBL] [Abstract][Full Text] [Related]
30. Intralymphatic Spread is a Rare Finding Associated With Poor Prognosis in Diffuse Large B-Cell Lymphoma With Extranodal Involvements.
Cheng CL; Su YC; Chao TY; Lin CW; Chou SC; Yao M; Kuo SH; Yu SC
Am J Surg Pathol; 2018 May; 42(5):616-624. PubMed ID: 29505426
[TBL] [Abstract][Full Text] [Related]
31. Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas.
Bhagavathi S; Sharathkumar A; Hunter S; Sung L; Kanhere R; Venturina MD; Wilson JD
Clin Neuropathol; 2008; 27(1):13-20. PubMed ID: 18257470
[TBL] [Abstract][Full Text] [Related]
32. Genotypic and phenotypic differences between nodal and extranodal diffuse large B-Cell lymphomas.
Al-Humood SA; Al-Qallaf AS; Alshemmari SH; Francis IM; Junaid TA; Marouf RA; Al-Mulla F
J Histochem Cytochem; 2011 Oct; 59(10):918-31. PubMed ID: 21832150
[TBL] [Abstract][Full Text] [Related]
33. Modified number of extranodal involved sites as a prognosticator in R-CHOP-treated patients with disseminated diffuse large B-cell lymphoma.
Yoo C; Kim S; Sohn BS; Kim JE; Yoon DH; Huh J; Lee DH; Kim SW; Lee JS; Suh C
Korean J Intern Med; 2010 Sep; 25(3):301-8. PubMed ID: 20830228
[TBL] [Abstract][Full Text] [Related]
34. [Extranodal diffuse large B-cell lymphoma--an organotypic disease?].
Ott G; Rosenwald A
Pathologe; 2007 Feb; 28(1):29-35. PubMed ID: 17211671
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of interleukin-20 correlates with favourable prognosis in diffuse large B-cell lymphoma.
Lu YS; Chiang PM; Huang YC; Yang SJ; Hung LY; Medeiros LJ; Chen YP; Chen TY; Chang MS; Chang KC
Pathology; 2023 Feb; 55(1):94-103. PubMed ID: 36175183
[TBL] [Abstract][Full Text] [Related]
36. Extranodal NK/T cell lymphoma and lymphomatoid granulomatosis in a patient with chronic lymphocytic leukaemia: Case report for a new perspective on Richter syndrome.
Abi-Rafeh J; Beamish IV; Haegert DG; Cournoyer D; Michel RP
Medicine (Baltimore); 2020 May; 99(19):e20106. PubMed ID: 32384485
[TBL] [Abstract][Full Text] [Related]
37. Prognostic differences of refractory/relapsed nodal and extranodal diffuse large B-cell lymphoma in the chimeric antigen receptor T cell therapy era.
Song Z; Xu L; Tang G; Gao L; Wang L; Ni X; Chen L; Chen J; Wang T; Feng D; Yu X; Yang J; Wang Y
Clin Chim Acta; 2022 Jul; 532():72-78. PubMed ID: 35660013
[TBL] [Abstract][Full Text] [Related]
38. Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas.
Rosenwald A; Ott G; Stilgenbauer S; Kalla J; Bredt M; Katzenberger T; Greiner A; Ott MM; Gawin B; Döhner H; Müller-Hermelink HK
Am J Pathol; 1999 Dec; 155(6):1817-21. PubMed ID: 10595910
[TBL] [Abstract][Full Text] [Related]
39. Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphoma.
Wu RY; Li YX; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Fang H; Ren H; Liu QF; Wang ZY; Qi SN; Lu NN; Chen B; Zhang XM; Zhou LQ; Liu XF; Yu ZH
Am J Clin Oncol; 2014 Feb; 37(1):41-6. PubMed ID: 22992625
[TBL] [Abstract][Full Text] [Related]
40. Head-and-neck stages I and II extranodal non-Hodgkin's lymphomas: real classification and selection for treatment modality.
Sasai K; Yamabe H; Kokubo M; Shibata T; Oya N; Nagata Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):153-60. PubMed ID: 10924985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
